(Q34362680)

1 August 2017

title

Efficacy and safety of treatment with rituximab for difficult steroid-resistant and -dependent nephrotic syndrome: multicentric report (English)

1 reference

1 August 2017

1 reference

1 reference

3

Stanley C Jordan

1 reference

1 August 2017

Ashima Gulati

1

1 reference

1 August 2017

Aditi Sinha

2

1 reference

1 August 2017

Pankaj Hari

4

1 reference

1 August 2017

Amit K Dinda

5

1 reference

1 August 2017

Sonika Sharma

6

1 reference

1 August 2017

Rajendra N Srivastava

7

1 reference

1 August 2017

Asha Moudgil

8

1 reference

1 August 2017

Arvind Bagga

9

1 reference

1 August 2017

publication date

26 August 2010

1 reference

Clinical Journal of the American Society of Nephrology

1 August 2017

published in

1 reference

1 August 2017

volume

5

1 reference

1 August 2017

issue

12

1 reference

1 August 2017

page(s)

2207-2212

1 reference

Rituximab pharmacokinetics during the management of acute idiopathic thrombotic thrombocytopenic purpura

1 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2994081

Targeting B cells in immune-mediated inflammatory disease: a comprehensive review of mechanisms of action and identification of biomarkers

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2994081

Single infusion of rituximab for persistent steroid-dependent minimal-change nephrotic syndrome after long-term cyclosporine

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2994081

Rituximab in refractory nephrotic syndrome.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2994081

Rituximab treatment in rheumatoid arthritis: how does it work?

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2994081

Long-term outcome of biopsy-proven, frequently relapsing minimal-change nephrotic syndrome in children

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2994081

Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2994081

Predictors of long-term outcome of children with idiopathic focal segmental glomerulosclerosis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2994081

Primer: Histopathology of calcineurin-inhibitor toxicity in renal allografts

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2994081

Therapeutic options for resistant lupus nephritis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2994081

Evaluation of the obese patient. Practical considerations

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2994081

Tacrolimus therapy in adults with steroid- and cyclophosphamide-resistant nephrotic syndrome and normal or mildly reduced GFR.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2994081

Fatal pulmonary fibrosis after rituximab administration

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2994081

Long-term outcome of idiopathic steroid-resistant nephrotic syndrome: a multicenter study

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2994081

Rituximab for refractory focal segmental glomerulosclerosis

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2994081

Targeted anti-cancer therapy using rituximab, a chimaeric anti-CD20 antibody (IDEC-C2B8) in the treatment of non-Hodgkin's B-cell lymphoma

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2994081

Prognostic significance of the early course of minimal change nephrotic syndrome: report of the International Study of Kidney Disease in Children.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2994081

Rituximab in patients with the steroid-resistant nephrotic syndrome

27 October 2018

1 reference

12 December 2020

Rituximab treatment for severe steroid- or cyclosporine-dependent nephrotic syndrome: a multicentric series of 22 cases

1 reference

12 December 2020

Nephrotic syndrome and rituximab: facts and perspectives

1 reference

12 December 2020

New therapies, new concerns: rituximab-associated lung injury

1 reference

12 December 2020

Rituximab efficiency in children with steroid-dependent nephrotic syndrome

1 reference

12 December 2020

Identifiers

DOI

10.2215/CJN.03470410

1 reference

1 August 2017

1 reference

1 August 2017

1 reference